Literature DB >> 28292434

Pancreatic Cancer Genomics 2.0: Profiling Metastases.

Eric A Collisson1, Anirban Maitra2.   

Abstract

Pancreatic ductal adenocarcinoma, even when diagnosed early, nearly always metastasizes. Recurrent mutations and genomic instability are early events in the disease. Two recent papers advance our understanding of how the cancer genome evolves as the primary tumor migrates from its origin in the pancreas to colonize distant metastatic sites.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28292434     DOI: 10.1016/j.ccell.2017.02.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  6 in total

1.  TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis.

Authors:  David Crottès; Yu-Hsiu T Lin; Christian J Peters; John M Gilchrist; Arun P Wiita; Yuh Nung Jan; Lily Yeh Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

2.  Deeper insights into long-term survival heterogeneity of pancreatic ductal adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses.

Authors:  Archana Bhardwaj; Claire Josse; Daniel Van Daele; Christophe Poulet; Marcela Chavez; Ingrid Struman; Kristel Van Steen
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

3.  Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma.

Authors:  Hongjin Wu; Weiwei Tian; Xiang Tai; Xuanpeng Li; Ziwei Li; Jing Shui; Juehua Yu; Zhihua Wang; Xiaosong Zhu
Journal:  BMC Genomics       Date:  2021-11-18       Impact factor: 3.969

4.  Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis.

Authors:  Matthew E Bechard; Rana Smalling; Akimasa Hayashi; Yi Zhong; Anna E Word; Sydney L Campbell; Amanda V Tran; Vivian L Weiss; Christine Iacobuzio-Donahue; Kathryn E Wellen; Oliver G McDonald
Journal:  Nat Commun       Date:  2020-08-13       Impact factor: 14.919

5.  Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis.

Authors:  Dongsheng Gu; Hai Lin; Xiaoli Zhang; Qipeng Fan; Shaoxiong Chen; Safi Shahda; Yunlong Liu; Jie Sun; Jingwu Xie
Journal:  Cancers (Basel)       Date:  2018-10-26       Impact factor: 6.639

6.  Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.

Authors:  Gustavo A Arias-Pinilla; Angus G Dalgleish; Satvinder Mudan; Izhar Bagwan; Anthony J Walker; Helmout Modjtahedi
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.